These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32720996)

  • 1. Trends in HIV Preexposure Prophylaxis Prescribing in the United States, 2012-2018.
    Song HJ; Squires P; Wilson D; Lo-Ciganic WH; Cook RL; Park H
    JAMA; 2020 Jul; 324(4):395-397. PubMed ID: 32720996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States.
    Rosenberg ES; Marcus JL
    Ann Epidemiol; 2018 Dec; 28(12):830-832. PubMed ID: 30224292
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
    Traeger MW; Patel P; Guy R; Hellard ME; Stoové MA;
    AIDS; 2021 Jan; 35(1):155-157. PubMed ID: 33273185
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone Prescribing in the United States, 2002-2016.
    Baillargeon J; Kuo YF; Westra JR; Urban RJ; Goodwin JS
    JAMA; 2018 Jul; 320(2):200-202. PubMed ID: 29998328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.
    Zhang C; McMahon J; Fiscella K; Przybyla S; Braksmajer A; LeBlanc N; Liu Y
    AIDS Patient Care STDS; 2019 Dec; 33(12):507-527. PubMed ID: 31821044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
    Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
    Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
    Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
    AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV pre-exposure prophylaxis: the primary care implications of prescribing restrictions.
    Wereski R
    Br J Gen Pract; 2017 Jul; 67(660):324-325. PubMed ID: 28663431
    [No Abstract]   [Full Text] [Related]  

  • 9. Adolescent Health Providers' Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to Youth at Risk of HIV Infection in the United States.
    Hart-Cooper GD; Allen I; Irwin CE; Scott H
    J Adolesc Health; 2018 Aug; 63(2):242-244. PubMed ID: 29843969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do confidentiality concerns impact pre-exposure prophylaxis willingness in emergency department adolescents and young adults?
    Moore KL; Dell S; Oliva MK; Hsieh YH; Rothman RE; Arrington-Sanders R
    Am J Emerg Med; 2019 Jun; 37(6):1206-1207. PubMed ID: 30446420
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in antibiotic prescribing.
    Wilcock M; Mackenzie I
    J Public Health Med; 2001 Dec; 23(4):357. PubMed ID: 11873903
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge, Attitudes, and PrEP Prescribing Practices of Health Care Providers in Philadelphia, PA.
    Carter MR; Aaron E; Nassau T; Brady KA
    J Prim Care Community Health; 2019; 10():2150132719878526. PubMed ID: 31578913
    [No Abstract]   [Full Text] [Related]  

  • 13. Concern as HIV prevention strategy languishes.
    Cohen J
    Science; 2018 Mar; 359(6381):1205. PubMed ID: 29590058
    [No Abstract]   [Full Text] [Related]  

  • 14. Preexposure prophylaxis use continues to evolve.
    Tobin SC
    AIDS; 2019 Apr; 33(5):N5. PubMed ID: 30882488
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular Safety Warnings and the Prescribing of Varenicline: An Interrupted Time-series Analysis.
    Filion KB; Eberg M; Azoulay L
    Epidemiology; 2016 Jul; 27(4):e28-9. PubMed ID: 27046129
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in antimicrobial drug prescribing among office-based physicians in the United States.
    McCaig LF; Hughes JM
    JAMA; 1995 Jan; 273(3):214-9. PubMed ID: 7807660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing clinician specialty influences adherence to PrEP.
    Masone MC
    Nat Rev Urol; 2024 Oct; 21(10):577. PubMed ID: 39271801
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation in use of broad-spectrum antibiotics for acute respiratory tract infection.
    Mainous AG; Hueston WJ
    JAMA; 2003 Jun; 289(21):2797; author reply 2797-8. PubMed ID: 12783910
    [No Abstract]   [Full Text] [Related]  

  • 19. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Being PrEPared - Preexposure Prophylaxis and HIV Disparities.
    Goldstein RH; Streed CG; Cahill SR
    N Engl J Med; 2018 Oct; 379(14):1293-1295. PubMed ID: 30230965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.